Cargando…
A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression
BACKGROUND: To facilitate indefinite proliferation, stem cells and most cancer cells require the activity of telomerase, which counteracts the successive shortening of telomeres caused by incomplete DNA replication at the very end of each chromosome. Human telomerase activity is often determined by...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640169/ https://www.ncbi.nlm.nih.gov/pubmed/26553065 http://dx.doi.org/10.1186/s13059-015-0791-1 |
_version_ | 1782400044678250496 |
---|---|
author | Xi, Linghe Schmidt, Jens C. Zaug, Arthur J. Ascarrunz, Dante R. Cech, Thomas R. |
author_facet | Xi, Linghe Schmidt, Jens C. Zaug, Arthur J. Ascarrunz, Dante R. Cech, Thomas R. |
author_sort | Xi, Linghe |
collection | PubMed |
description | BACKGROUND: To facilitate indefinite proliferation, stem cells and most cancer cells require the activity of telomerase, which counteracts the successive shortening of telomeres caused by incomplete DNA replication at the very end of each chromosome. Human telomerase activity is often determined by the expression level of telomerase reverse transcriptase (TERT), the catalytic subunit of the ribonucleoprotein complex. The low expression level of TERT and the lack of adequate antibodies have made it difficult to study telomerase-related processes in human cells. RESULTS: To overcome the low CRISPR-Cas9 editing efficiency at the TERT locus, we develop a two-step “pop-in/pop-out” strategy to enrich cells that underwent homologous recombination (HR). Using this technique, we fuse an N-terminal FLAG-SNAP-tag to TERT, which allows us to reliably detect TERT in western blots, immunopurify it for biochemical analysis, and determine its subcellular localization by fluorescence microscopy. TERT co-localizes detectably with only 5–7 % of the telomeres at a time in S-phase HeLa cells; no nucleolar localization is detected. Furthermore, we extend this approach to perform single base-pair modifications in the TERT promoter; reverting a recurrent cancer-associated TERT promoter mutation in a urothelial cancer cell line results in decreased telomerase activity, indicating the mutation is causal for telomerase reactivation. CONCLUSIONS: We develop a two-step CRISPR-Cas9 genome editing strategy to introduce precise modifications at the endogenous TERT locus in human cell lines. This method provides a useful tool for studying telomerase biology, and suggests a general approach to edit loci with low targeting efficiency and to purify and visualize low abundance proteins. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-015-0791-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4640169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46401692015-11-11 A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression Xi, Linghe Schmidt, Jens C. Zaug, Arthur J. Ascarrunz, Dante R. Cech, Thomas R. Genome Biol Research BACKGROUND: To facilitate indefinite proliferation, stem cells and most cancer cells require the activity of telomerase, which counteracts the successive shortening of telomeres caused by incomplete DNA replication at the very end of each chromosome. Human telomerase activity is often determined by the expression level of telomerase reverse transcriptase (TERT), the catalytic subunit of the ribonucleoprotein complex. The low expression level of TERT and the lack of adequate antibodies have made it difficult to study telomerase-related processes in human cells. RESULTS: To overcome the low CRISPR-Cas9 editing efficiency at the TERT locus, we develop a two-step “pop-in/pop-out” strategy to enrich cells that underwent homologous recombination (HR). Using this technique, we fuse an N-terminal FLAG-SNAP-tag to TERT, which allows us to reliably detect TERT in western blots, immunopurify it for biochemical analysis, and determine its subcellular localization by fluorescence microscopy. TERT co-localizes detectably with only 5–7 % of the telomeres at a time in S-phase HeLa cells; no nucleolar localization is detected. Furthermore, we extend this approach to perform single base-pair modifications in the TERT promoter; reverting a recurrent cancer-associated TERT promoter mutation in a urothelial cancer cell line results in decreased telomerase activity, indicating the mutation is causal for telomerase reactivation. CONCLUSIONS: We develop a two-step CRISPR-Cas9 genome editing strategy to introduce precise modifications at the endogenous TERT locus in human cell lines. This method provides a useful tool for studying telomerase biology, and suggests a general approach to edit loci with low targeting efficiency and to purify and visualize low abundance proteins. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-015-0791-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-10 2015 /pmc/articles/PMC4640169/ /pubmed/26553065 http://dx.doi.org/10.1186/s13059-015-0791-1 Text en © Xi et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Xi, Linghe Schmidt, Jens C. Zaug, Arthur J. Ascarrunz, Dante R. Cech, Thomas R. A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression |
title | A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression |
title_full | A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression |
title_fullStr | A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression |
title_full_unstemmed | A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression |
title_short | A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression |
title_sort | novel two-step genome editing strategy with crispr-cas9 provides new insights into telomerase action and tert gene expression |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640169/ https://www.ncbi.nlm.nih.gov/pubmed/26553065 http://dx.doi.org/10.1186/s13059-015-0791-1 |
work_keys_str_mv | AT xilinghe anoveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression AT schmidtjensc anoveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression AT zaugarthurj anoveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression AT ascarrunzdanter anoveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression AT cechthomasr anoveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression AT xilinghe noveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression AT schmidtjensc noveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression AT zaugarthurj noveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression AT ascarrunzdanter noveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression AT cechthomasr noveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression |